skip to Main Content

Study Finds New Way to Make Chemotherapy More Effective Against Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Pancreatic adenocarcinoma (PDAC) is a lethal malignancy that most often is resistant to chemotherapy. Researchers have been searching for ways to increase the sensitivity of the tumors to cancer-fighting drugs.

A Mayo Clinic-led study published today opens a promising new front in that battle. Read more . . . 

Back To Top